Neuroleptic malignant syndrome is a rare, but potentially life-threatening adverse event associated with the use of neuroleptic agents. We describe the case of a 47-year-old schizophrenic woman who was treated with clozapine for years. The patient developed acute renal failure with pulmonary edema, and underwent mechanical ventilation and hemodialysis.
Citations
Citations to this article as recorded by
Rhabdomyolysis caused by neuroleptic malignant syndrome requiring long-term hemodialysis: A case report and literature review Kenji Nakata, Hideyo Oguchi, Yosuke Sasaki, Atsushi Yamada, Kotaro Okamoto, Kaori Itsukaichi, Eriko Fukui, Ken Sakai Internal Medicine.2026;[Epub] CrossRef
Myotube-specific vulnerability to clozapine Gloria Buffi, Mara Fiorani, Andrea Guidarelli, Nazanin Bagherlou, Andrea Spina, Lorenzo Scocchia, Giorgia Maria Renna, Ester Zito, Orazio Cantoni Biomedicine & Pharmacotherapy.2025; 192: 118661. CrossRef
Neuroleptic Malignant Syndrome (NMS) Induced by Clozapine at a Very Low Dose Chayan Kanti Manna, Moumita Mondal Bengal Journal of Psychiatry.2024; 29: 52. CrossRef
Toxicity and Adverse Effects in Clozapine-Related Presentations to a Medical Toxicology Service in Western Sydney Pramod Chandru, Naren Gunja Journal of Medical Toxicology.2023; 19(4): 374. CrossRef